Does the media prefer TMCI or STAA?

In the previous week, STAAR Surgical had 14 more articles in the media than Treace Medical Concepts. MarketBeat recorded 21 mentions for STAAR Surgical and 7 mentions for Treace Medical Concepts. STAAR Surgical's average media sentiment score of 0.45 beat Treace Medical Concepts' score of 0.34 indicating that STAAR Surgical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Treace Medical Concepts 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral STAAR Surgical 7 Very Positive mention(s) 3 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to IRMD or TMCI?

In the previous week, iRadimed and iRadimed both had 7 articles in the media. iRadimed's average media sentiment score of 0.52 beat Treace Medical Concepts' score of 0.34 indicating that iRadimed is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment iRadimed 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Treace Medical Concepts 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to BVS or TMCI?

In the previous week, Bioventus and Bioventus both had 7 articles in the media. Bioventus' average media sentiment score of 1.14 beat Treace Medical Concepts' score of 0.34 indicating that Bioventus is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bioventus 4 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Treace Medical Concepts 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor DRTS or TMCI?

In the previous week, Alpha Tau Medical had 19 more articles in the media than Treace Medical Concepts. MarketBeat recorded 26 mentions for Alpha Tau Medical and 7 mentions for Treace Medical Concepts. Treace Medical Concepts' average media sentiment score of 0.34 beat Alpha Tau Medical's score of 0.05 indicating that Treace Medical Concepts is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alpha Tau Medical 6 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Treace Medical Concepts 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor PRCT or TMCI?

In the previous week, PROCEPT BioRobotics had 43 more articles in the media than Treace Medical Concepts. MarketBeat recorded 50 mentions for PROCEPT BioRobotics and 7 mentions for Treace Medical Concepts. Treace Medical Concepts' average media sentiment score of 0.34 beat PROCEPT BioRobotics' score of 0.22 indicating that Treace Medical Concepts is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PROCEPT BioRobotics 5 Very Positive mention(s) 5 Positive mention(s) 35 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral Treace Medical Concepts 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Treace Medical Concepts (TMCI) Competitors

$4.79 +0.28 (+6.21%)

Closing price 04:00 PM Eastern

Extended Trading

$4.78 0.00 (-0.10%)

As of 07:34 PM Eastern

Compare

TMCI vs. STAA, IRMD, BVS, DRTS, and PRCT

Should you buy Treace Medical Concepts stock or one of its competitors? Treace Medical Concepts's main competitors and comparable companies include STAAR Surgical (STAA), iRadimed (IRMD), Bioventus (BVS), Alpha Tau Medical (DRTS), and PROCEPT BioRobotics (PRCT). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Treace Medical Concepts compare to STAAR Surgical?

Treace Medical Concepts (NASDAQ:TMCI) and STAAR Surgical (NASDAQ:STAA) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, profitability, dividends, risk and analyst recommendations.

STAAR Surgical has a net margin of 1.13% compared to Treace Medical Concepts' net margin of -28.99%. STAAR Surgical's return on equity of 9.05% beat Treace Medical Concepts' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Treace Medical Concepts	-28.99%	-71.37%	-30.49%
STAAR Surgical	1.13%	9.05%	6.99%

84.1% of Treace Medical Concepts shares are held by institutional investors. Comparatively, 96.7% of STAAR Surgical shares are held by institutional investors. 23.4% of Treace Medical Concepts shares are held by company insiders. Comparatively, 39.9% of STAAR Surgical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Treace Medical Concepts has higher earnings, but lower revenue than STAAR Surgical. STAAR Surgical is trading at a lower price-to-earnings ratio than Treace Medical Concepts, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Treace Medical Concepts	$212.69M	1.46	-$59M	-$0.93	N/A
STAAR Surgical	$239.44M	5.44	-$80.45M	-$0.43	N/A

Treace Medical Concepts currently has a consensus price target of $5.17, indicating a potential upside of 7.93%. STAAR Surgical has a consensus price target of $27.80, indicating a potential upside of 6.19%. Given Treace Medical Concepts' higher possible upside, analysts plainly believe Treace Medical Concepts is more favorable than STAAR Surgical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Treace Medical Concepts	2 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.86
STAAR Surgical	3 Sell rating(s)	7 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.08

In the previous week, STAAR Surgical had 14 more articles in the media than Treace Medical Concepts. MarketBeat recorded 21 mentions for STAAR Surgical and 7 mentions for Treace Medical Concepts. STAAR Surgical's average media sentiment score of 0.45 beat Treace Medical Concepts' score of 0.34 indicating that STAAR Surgical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Treace Medical Concepts	1 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
STAAR Surgical	7 Very Positive mention(s)	3 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Treace Medical Concepts has a beta of 1.37, meaning that its share price is 37% more volatile than the broader market. Comparatively, STAAR Surgical has a beta of 1.26, meaning that its share price is 26% more volatile than the broader market.

Summary

STAAR Surgical beats Treace Medical Concepts on 14 of the 17 factors compared between the two stocks.

How does Treace Medical Concepts compare to iRadimed?

iRadimed (NASDAQ:IRMD) and Treace Medical Concepts (NASDAQ:TMCI) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, media sentiment, analyst recommendations, dividends and earnings.

iRadimed has higher earnings, but lower revenue than Treace Medical Concepts. Treace Medical Concepts is trading at a lower price-to-earnings ratio than iRadimed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iRadimed	$83.81M	13.27	$22.48M	$1.79	48.58
Treace Medical Concepts	$212.69M	1.46	-$59M	-$0.93	N/A

92.3% of iRadimed shares are held by institutional investors. Comparatively, 84.1% of Treace Medical Concepts shares are held by institutional investors. 34.6% of iRadimed shares are held by insiders. Comparatively, 23.4% of Treace Medical Concepts shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, iRadimed and iRadimed both had 7 articles in the media. iRadimed's average media sentiment score of 0.52 beat Treace Medical Concepts' score of 0.34 indicating that iRadimed is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
iRadimed	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
Treace Medical Concepts	1 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

iRadimed currently has a consensus target price of $120.00, indicating a potential upside of 38.01%. Treace Medical Concepts has a consensus target price of $5.17, indicating a potential upside of 7.93%. Given iRadimed's stronger consensus rating and higher possible upside, analysts plainly believe iRadimed is more favorable than Treace Medical Concepts.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iRadimed	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.80
Treace Medical Concepts	2 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.86

iRadimed has a net margin of 26.70% compared to Treace Medical Concepts' net margin of -28.99%. iRadimed's return on equity of 23.45% beat Treace Medical Concepts' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
iRadimed	26.70%	23.45%	20.36%
Treace Medical Concepts	-28.99%	-71.37%	-30.49%

iRadimed has a beta of 0.9, indicating that its share price is 10% less volatile than the broader market. Comparatively, Treace Medical Concepts has a beta of 1.37, indicating that its share price is 37% more volatile than the broader market.

Summary

iRadimed beats Treace Medical Concepts on 14 of the 16 factors compared between the two stocks.

How does Treace Medical Concepts compare to Bioventus?

Bioventus (NASDAQ:BVS) and Treace Medical Concepts (NASDAQ:TMCI) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their risk, profitability, earnings, institutional ownership, analyst recommendations, valuation, dividends and media sentiment.

Bioventus has a net margin of 9.36% compared to Treace Medical Concepts' net margin of -28.99%. Bioventus' return on equity of 28.08% beat Treace Medical Concepts' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bioventus	9.36%	28.08%	9.82%
Treace Medical Concepts	-28.99%	-71.37%	-30.49%

Bioventus has a beta of 0.63, suggesting that its stock price is 37% less volatile than the broader market. Comparatively, Treace Medical Concepts has a beta of 1.37, suggesting that its stock price is 37% more volatile than the broader market.

Bioventus presently has a consensus price target of $16.25, indicating a potential upside of 13.96%. Treace Medical Concepts has a consensus price target of $5.17, indicating a potential upside of 7.93%. Given Bioventus' stronger consensus rating and higher probable upside, analysts plainly believe Bioventus is more favorable than Treace Medical Concepts.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bioventus	0 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	3.00
Treace Medical Concepts	2 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.86

Bioventus has higher revenue and earnings than Treace Medical Concepts. Treace Medical Concepts is trading at a lower price-to-earnings ratio than Bioventus, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bioventus	$568.09M	2.11	$22.73M	$0.77	18.52
Treace Medical Concepts	$212.69M	1.46	-$59M	-$0.93	N/A

In the previous week, Bioventus and Bioventus both had 7 articles in the media. Bioventus' average media sentiment score of 1.14 beat Treace Medical Concepts' score of 0.34 indicating that Bioventus is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bioventus	4 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Treace Medical Concepts	1 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

62.9% of Bioventus shares are owned by institutional investors. Comparatively, 84.1% of Treace Medical Concepts shares are owned by institutional investors. 33.5% of Bioventus shares are owned by company insiders. Comparatively, 23.4% of Treace Medical Concepts shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Bioventus beats Treace Medical Concepts on 14 of the 16 factors compared between the two stocks.

How does Treace Medical Concepts compare to Alpha Tau Medical?

Alpha Tau Medical (NASDAQ:DRTS) and Treace Medical Concepts (NASDAQ:TMCI) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, profitability, media sentiment, valuation, risk and earnings.

2.7% of Alpha Tau Medical shares are held by institutional investors. Comparatively, 84.1% of Treace Medical Concepts shares are held by institutional investors. 39.5% of Alpha Tau Medical shares are held by company insiders. Comparatively, 23.4% of Treace Medical Concepts shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, Alpha Tau Medical had 19 more articles in the media than Treace Medical Concepts. MarketBeat recorded 26 mentions for Alpha Tau Medical and 7 mentions for Treace Medical Concepts. Treace Medical Concepts' average media sentiment score of 0.34 beat Alpha Tau Medical's score of 0.05 indicating that Treace Medical Concepts is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alpha Tau Medical	6 Very Positive mention(s)	2 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Treace Medical Concepts	1 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Alpha Tau Medical has a beta of 1.17, meaning that its stock price is 17% more volatile than the broader market. Comparatively, Treace Medical Concepts has a beta of 1.37, meaning that its stock price is 37% more volatile than the broader market.

Alpha Tau Medical has a net margin of 0.00% compared to Treace Medical Concepts' net margin of -28.99%. Treace Medical Concepts' return on equity of -71.37% beat Alpha Tau Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alpha Tau Medical	N/A	-138.12%	-81.68%
Treace Medical Concepts	-28.99%	-71.37%	-30.49%

Alpha Tau Medical has higher earnings, but lower revenue than Treace Medical Concepts. Alpha Tau Medical is trading at a lower price-to-earnings ratio than Treace Medical Concepts, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alpha Tau Medical	N/A	N/A	-$42.63M	-$1.04	N/A
Treace Medical Concepts	$212.69M	1.46	-$59M	-$0.93	N/A

Alpha Tau Medical currently has a consensus target price of $12.80, suggesting a potential downside of 10.18%. Treace Medical Concepts has a consensus target price of $5.17, suggesting a potential upside of 7.93%. Given Treace Medical Concepts' higher possible upside, analysts clearly believe Treace Medical Concepts is more favorable than Alpha Tau Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alpha Tau Medical	1 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.50
Treace Medical Concepts	2 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.86

Summary

Treace Medical Concepts beats Alpha Tau Medical on 9 of the 15 factors compared between the two stocks.

How does Treace Medical Concepts compare to PROCEPT BioRobotics?

PROCEPT BioRobotics (NASDAQ:PRCT) and Treace Medical Concepts (NASDAQ:TMCI) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, risk, earnings, profitability, media sentiment, valuation and analyst recommendations.

PROCEPT BioRobotics currently has a consensus price target of $28.00, indicating a potential upside of 29.33%. Treace Medical Concepts has a consensus price target of $5.17, indicating a potential upside of 7.93%. Given PROCEPT BioRobotics' stronger consensus rating and higher possible upside, research analysts clearly believe PROCEPT BioRobotics is more favorable than Treace Medical Concepts.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PROCEPT BioRobotics	2 Sell rating(s)	10 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.19
Treace Medical Concepts	2 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.86

In the previous week, PROCEPT BioRobotics had 43 more articles in the media than Treace Medical Concepts. MarketBeat recorded 50 mentions for PROCEPT BioRobotics and 7 mentions for Treace Medical Concepts. Treace Medical Concepts' average media sentiment score of 0.34 beat PROCEPT BioRobotics' score of 0.22 indicating that Treace Medical Concepts is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
PROCEPT BioRobotics	5 Very Positive mention(s)	5 Positive mention(s)	35 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral
Treace Medical Concepts	1 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Treace Medical Concepts has a net margin of -28.99% compared to PROCEPT BioRobotics' net margin of -32.53%. PROCEPT BioRobotics' return on equity of -30.62% beat Treace Medical Concepts' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PROCEPT BioRobotics	-32.53%	-30.62%	-22.10%
Treace Medical Concepts	-28.99%	-71.37%	-30.49%

Treace Medical Concepts has lower revenue, but higher earnings than PROCEPT BioRobotics. PROCEPT BioRobotics is trading at a lower price-to-earnings ratio than Treace Medical Concepts, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PROCEPT BioRobotics	$308.05M	4.02	-$95.57M	-$1.94	N/A
Treace Medical Concepts	$212.69M	1.46	-$59M	-$0.93	N/A

PROCEPT BioRobotics has a beta of 0.89, meaning that its stock price is 11% less volatile than the broader market. Comparatively, Treace Medical Concepts has a beta of 1.37, meaning that its stock price is 37% more volatile than the broader market.

89.5% of PROCEPT BioRobotics shares are owned by institutional investors. Comparatively, 84.1% of Treace Medical Concepts shares are owned by institutional investors. 4.0% of PROCEPT BioRobotics shares are owned by insiders. Comparatively, 23.4% of Treace Medical Concepts shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

PROCEPT BioRobotics beats Treace Medical Concepts on 10 of the 17 factors compared between the two stocks.

Get Treace Medical Concepts News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TMCI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TMCI vs. The Competition

Export

Metric	Treace Medical Concepts	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$293.31M	$5.95B	$7.06B	$13.10B
Dividend Yield	N/A	1.76%	2.57%	10.45%
P/E Ratio	-5.15	26.22	269.06	25.28
Price / Sales	1.46	63.24	592.96	87.71
Price / Cash	N/A	33.92	70.48	50.90
Price / Book	4.61	6.10	12.91	6.24
Net Income	-$59M	$148.67M	$3.45B	$347.60M
7 Day Performance	0.63%	1.84%	1.12%	1.07%
1 Month Performance	7.88%	4.56%	1.79%	1.03%
1 Year Performance	-31.08%	8.67%	67.69%	20.77%

Treace Medical Concepts Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TMCI Treace Medical Concepts	2.3962 of 5 stars	$4.79 +6.2%	$5.17 +7.9%	-34.6%	$293.31M	$212.69M	N/A	250	Earnings Report
STAA STAAR Surgical	2.608 of 5 stars	$24.12 -0.9%	$26.94 +11.7%	-10.2%	$1.21B	$239.44M	N/A	1,211	News Coverage Analyst Forecast
IRMD iRadimed	3.2629 of 5 stars	$93.13 +1.7%	$120.00 +28.9%	+22.8%	$1.17B	$83.81M	52.03	110
BVS Bioventus	4.5915 of 5 stars	$13.42 -0.4%	$14.75 +9.9%	+84.5%	$1.13B	$568.09M	32.73	1,200
DRTS Alpha Tau Medical	1.35 of 5 stars	$13.08 +9.7%	$12.60 -3.7%	+324.0%	$1.08B	N/A	N/A	80	Trending News Earnings Report Analyst Forecast Insider Trade Analyst Revision

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:TMCI) was last updated on 8/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Treace Medical Concepts (TMCI) Competitors

TMCI vs. STAA, IRMD, BVS, DRTS, and PRCT

How does Treace Medical Concepts compare to STAAR Surgical?

Summary

How does Treace Medical Concepts compare to iRadimed?

Summary

How does Treace Medical Concepts compare to Bioventus?

Summary

How does Treace Medical Concepts compare to Alpha Tau Medical?

Summary

How does Treace Medical Concepts compare to PROCEPT BioRobotics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TMCI vs. The Competition

Treace Medical Concepts Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Treace Medical Concepts (TMCI) Competitors

TMCI vs. STAA, IRMD, BVS, DRTS, and PRCT

How does Treace Medical Concepts compare to STAAR Surgical?

Is TMCI or STAA more profitable?

Do insiders & institutionals have more ownership in TMCI or STAA?

Which has stronger earnings & valuation, TMCI or STAA?

Do analysts prefer TMCI or STAA?

Does the media prefer TMCI or STAA?

Which has more risk and volatility, TMCI or STAA?

Summary

How does Treace Medical Concepts compare to iRadimed?

Which has stronger valuation and earnings, IRMD or TMCI?

Do insiders and institutionals believe in IRMD or TMCI?

Does the media refer more to IRMD or TMCI?

Do analysts recommend IRMD or TMCI?

Is IRMD or TMCI more profitable?

Which has more volatility & risk, IRMD or TMCI?

Summary

How does Treace Medical Concepts compare to Bioventus?

Is BVS or TMCI more profitable?

Which has more volatility & risk, BVS or TMCI?

Do analysts rate BVS or TMCI?

Which has better earnings and valuation, BVS or TMCI?

Does the media refer more to BVS or TMCI?

Do insiders & institutionals believe in BVS or TMCI?

Summary

How does Treace Medical Concepts compare to Alpha Tau Medical?

Do institutionals and insiders have more ownership in DRTS or TMCI?

Does the media favor DRTS or TMCI?

Which has more risk & volatility, DRTS or TMCI?

Is DRTS or TMCI more profitable?

Which has stronger earnings and valuation, DRTS or TMCI?

Do analysts recommend DRTS or TMCI?

Summary

How does Treace Medical Concepts compare to PROCEPT BioRobotics?

Do analysts rate PRCT or TMCI?

Does the media favor PRCT or TMCI?

Is PRCT or TMCI more profitable?

Which has better valuation & earnings, PRCT or TMCI?

Which has more volatility and risk, PRCT or TMCI?

Do institutionals & insiders have more ownership in PRCT or TMCI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TMCI vs. The Competition

Treace Medical Concepts Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools